Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. / Abrams, J K; Johnson, P L; Hay-Schmidt, Anders; Mikkelsen, J D; Shekhar, A; Lowry, C A.

In: Neuroscience, Vol. 133, No. 4, 2005, p. 983-97.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Abrams, JK, Johnson, PL, Hay-Schmidt, A, Mikkelsen, JD, Shekhar, A & Lowry, CA 2005, 'Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs', Neuroscience, vol. 133, no. 4, pp. 983-97. https://doi.org/10.1016/j.neuroscience.2005.03.025

APA

Abrams, J. K., Johnson, P. L., Hay-Schmidt, A., Mikkelsen, J. D., Shekhar, A., & Lowry, C. A. (2005). Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience, 133(4), 983-97. https://doi.org/10.1016/j.neuroscience.2005.03.025

Vancouver

Abrams JK, Johnson PL, Hay-Schmidt A, Mikkelsen JD, Shekhar A, Lowry CA. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience. 2005;133(4):983-97. https://doi.org/10.1016/j.neuroscience.2005.03.025

Author

Abrams, J K ; Johnson, P L ; Hay-Schmidt, Anders ; Mikkelsen, J D ; Shekhar, A ; Lowry, C A. / Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. In: Neuroscience. 2005 ; Vol. 133, No. 4. pp. 983-97.

Bibtex

@article{8052381c924f4f8492d4e5abe94fdb2b,
title = "Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs",
abstract = "Serotonergic systems play important roles in modulating behavioral arousal, including behavioral arousal and vigilance associated with anxiety states. To further our understanding of the neural systems associated with increases in anxiety states, we investigated the effects of multiple anxiogenic drugs on topographically organized subpopulations of serotonergic neurons using double immunohistochemical staining for c-Fos and tryptophan hydroxylase combined with topographical analysis of the rat dorsal raphe nucleus (DR). Anxiogenic drugs with diverse pharmacological properties including the adenosine receptor antagonist caffeine, the serotonin 5-HT2A/2C receptor agonist m-chlorophenyl piperazine (mCPP), the alpha2-adrenoreceptor antagonist yohimbine, and the benzodiazepine receptor partial inverse agonist N-methyl-beta-carboline-3-carboxamide (FG-7142) induced increases in behavioral arousal and vigilance behaviors consistent with an increase in anxiety state. In addition, these anxiogenic drugs, excluding yohimbine, had convergent actions on an anatomically-defined subset of serotonergic neurons within the middle and caudal, dorsal subdivision of the DR. High resolution topographical analysis revealed that at the mid-rostrocaudal level, caffeine and FG-7142 had convergent effects on c-Fos expression in serotonergic neurons that were restricted to a previously undefined region, which we have named the shell region of the dorsal part of the dorsal raphe nucleus (DRDSh), that overlaps the anatomical border between the dorsal part of the dorsal raphe nucleus, the ventral part of the dorsal raphe nucleus (DRV), and the ventrolateral part of the dorsal raphe nucleus (DRVL). Retrograde tracing methods revealed that DRDSh contains large numbers of neurons projecting to the basolateral amygdaloid nucleus, a forebrain structure important for emotional appraisal and modulation of anxiety-related physiological and behavioral responses. Together these findings support the hypothesis that there is a functional topographical organization in the DR and are consistent with the hypothesis that anxiogenic drugs have selective actions on a subpopulation of serotonergic neurons projecting to a distributed central autonomic and emotional motor control system regulating anxiety states and anxiety-related physiological and behavioral responses.",
keywords = "Adrenergic alpha-Antagonists, Analysis of Variance, Animals, Anti-Anxiety Agents, Arousal, Behavior, Animal, Blotting, Western, Brain, Brain Mapping, Caffeine, Carbolines, Cell Count, Central Nervous System Stimulants, Feeding Behavior, GABA Antagonists, Gene Expression Regulation, Immunohistochemistry, Male, Neural Pathways, Neurons, Piperazines, Proto-Oncogene Proteins c-fos, Raphe Nuclei, Rats, Rats, Wistar, Serotonin, Serotonin Receptor Agonists, Stilbamidines, Time Factors, Tryptophan Hydroxylase, Video Recording, Yohimbine",
author = "Abrams, {J K} and Johnson, {P L} and Anders Hay-Schmidt and Mikkelsen, {J D} and A Shekhar and Lowry, {C A}",
year = "2005",
doi = "10.1016/j.neuroscience.2005.03.025",
language = "English",
volume = "133",
pages = "983--97",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Pergamon Press",
number = "4",

}

RIS

TY - JOUR

T1 - Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs

AU - Abrams, J K

AU - Johnson, P L

AU - Hay-Schmidt, Anders

AU - Mikkelsen, J D

AU - Shekhar, A

AU - Lowry, C A

PY - 2005

Y1 - 2005

N2 - Serotonergic systems play important roles in modulating behavioral arousal, including behavioral arousal and vigilance associated with anxiety states. To further our understanding of the neural systems associated with increases in anxiety states, we investigated the effects of multiple anxiogenic drugs on topographically organized subpopulations of serotonergic neurons using double immunohistochemical staining for c-Fos and tryptophan hydroxylase combined with topographical analysis of the rat dorsal raphe nucleus (DR). Anxiogenic drugs with diverse pharmacological properties including the adenosine receptor antagonist caffeine, the serotonin 5-HT2A/2C receptor agonist m-chlorophenyl piperazine (mCPP), the alpha2-adrenoreceptor antagonist yohimbine, and the benzodiazepine receptor partial inverse agonist N-methyl-beta-carboline-3-carboxamide (FG-7142) induced increases in behavioral arousal and vigilance behaviors consistent with an increase in anxiety state. In addition, these anxiogenic drugs, excluding yohimbine, had convergent actions on an anatomically-defined subset of serotonergic neurons within the middle and caudal, dorsal subdivision of the DR. High resolution topographical analysis revealed that at the mid-rostrocaudal level, caffeine and FG-7142 had convergent effects on c-Fos expression in serotonergic neurons that were restricted to a previously undefined region, which we have named the shell region of the dorsal part of the dorsal raphe nucleus (DRDSh), that overlaps the anatomical border between the dorsal part of the dorsal raphe nucleus, the ventral part of the dorsal raphe nucleus (DRV), and the ventrolateral part of the dorsal raphe nucleus (DRVL). Retrograde tracing methods revealed that DRDSh contains large numbers of neurons projecting to the basolateral amygdaloid nucleus, a forebrain structure important for emotional appraisal and modulation of anxiety-related physiological and behavioral responses. Together these findings support the hypothesis that there is a functional topographical organization in the DR and are consistent with the hypothesis that anxiogenic drugs have selective actions on a subpopulation of serotonergic neurons projecting to a distributed central autonomic and emotional motor control system regulating anxiety states and anxiety-related physiological and behavioral responses.

AB - Serotonergic systems play important roles in modulating behavioral arousal, including behavioral arousal and vigilance associated with anxiety states. To further our understanding of the neural systems associated with increases in anxiety states, we investigated the effects of multiple anxiogenic drugs on topographically organized subpopulations of serotonergic neurons using double immunohistochemical staining for c-Fos and tryptophan hydroxylase combined with topographical analysis of the rat dorsal raphe nucleus (DR). Anxiogenic drugs with diverse pharmacological properties including the adenosine receptor antagonist caffeine, the serotonin 5-HT2A/2C receptor agonist m-chlorophenyl piperazine (mCPP), the alpha2-adrenoreceptor antagonist yohimbine, and the benzodiazepine receptor partial inverse agonist N-methyl-beta-carboline-3-carboxamide (FG-7142) induced increases in behavioral arousal and vigilance behaviors consistent with an increase in anxiety state. In addition, these anxiogenic drugs, excluding yohimbine, had convergent actions on an anatomically-defined subset of serotonergic neurons within the middle and caudal, dorsal subdivision of the DR. High resolution topographical analysis revealed that at the mid-rostrocaudal level, caffeine and FG-7142 had convergent effects on c-Fos expression in serotonergic neurons that were restricted to a previously undefined region, which we have named the shell region of the dorsal part of the dorsal raphe nucleus (DRDSh), that overlaps the anatomical border between the dorsal part of the dorsal raphe nucleus, the ventral part of the dorsal raphe nucleus (DRV), and the ventrolateral part of the dorsal raphe nucleus (DRVL). Retrograde tracing methods revealed that DRDSh contains large numbers of neurons projecting to the basolateral amygdaloid nucleus, a forebrain structure important for emotional appraisal and modulation of anxiety-related physiological and behavioral responses. Together these findings support the hypothesis that there is a functional topographical organization in the DR and are consistent with the hypothesis that anxiogenic drugs have selective actions on a subpopulation of serotonergic neurons projecting to a distributed central autonomic and emotional motor control system regulating anxiety states and anxiety-related physiological and behavioral responses.

KW - Adrenergic alpha-Antagonists

KW - Analysis of Variance

KW - Animals

KW - Anti-Anxiety Agents

KW - Arousal

KW - Behavior, Animal

KW - Blotting, Western

KW - Brain

KW - Brain Mapping

KW - Caffeine

KW - Carbolines

KW - Cell Count

KW - Central Nervous System Stimulants

KW - Feeding Behavior

KW - GABA Antagonists

KW - Gene Expression Regulation

KW - Immunohistochemistry

KW - Male

KW - Neural Pathways

KW - Neurons

KW - Piperazines

KW - Proto-Oncogene Proteins c-fos

KW - Raphe Nuclei

KW - Rats

KW - Rats, Wistar

KW - Serotonin

KW - Serotonin Receptor Agonists

KW - Stilbamidines

KW - Time Factors

KW - Tryptophan Hydroxylase

KW - Video Recording

KW - Yohimbine

U2 - 10.1016/j.neuroscience.2005.03.025

DO - 10.1016/j.neuroscience.2005.03.025

M3 - Journal article

C2 - 15916857

VL - 133

SP - 983

EP - 997

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 4

ER -

ID: 47928621